openPR Logo
Press release

euroscript implements Fast-track CMS solution at Astellas Pharma Europe

12-16-2009 10:20 AM CET | IT, New Media & Software

Press release from: euroscript International S.A.

Bertrange/Eindhoven, 15 December 2009 – euroscript announced today that its subsidiary euroscript Delt Netherlands has won a Fast-track CMS project with Astellas Pharma Europe in the Netherlands.

euroscript's Fast-track CMS solution is the only configurable solution that enables companies to easily deploy a well-fitted CMS within their EMC environment within a couple of weeks. The solution is based on C6 and EMC | Documentum technology.

Within the initial 3-month project phase, euroscript will implement a Fast-track CMS solution focusing on archiving and retrieval functionalities at Astellas’ Technology, Supply Chain and Manufacturing (TSCM) department. Further solution enhancement and roll-out to other departments and subsidiaries of Astellas worldwide will be discussed in early 2010.

Astellas Pharma aims to modernize its document management system, as the system needs to enable document validation and to ensure proper management of status, ownership, version control, and search-find tools.

To meet Astellas’ requirements, euroscript will follow an iterative approach in implementing the solution. euroscript will work closely with representative users of Astellas’ TSCM department to ensure the system suits Astellas’ actual business requirements. The availability of system prototypes for test and validation by Astellas’ representative users will have an immediate effect on user acceptance and productivity. Thus, the system will also prove its effectiveness and adherence to compliance and security requirements.

"We are pleased to support Astellas Pharma Europe in improving their document management system", said René Blanken, Managing Director of euroscript Delt Netherlands bv. "This implementation of our Fast-track CMS solution in the Netherlands demonstrates our competence in realizing secure content and document management solutions as well as our strong expertise in both C6 and EMC | Documentum applications."


About Astellas Pharma Europe

Astellas Pharma Europe Ltd. is the European subsidiary of Astellas. Astellas Europe employs approximately 3,200 people in Europe and South Africa across Sales and Marketing, Research & Development (R&D), and Manufacturing. Astellas Europe has 20 Sales and Marketing affiliates, three Manufacturing plants, and one R&D centre. Astellas Europe, through Astellas Pharma International, is also responsible for the distribution of the company's products in multiple markets in the Middle East and Africa. Astellas Europe is headquartered just outside London, in Staines.

Astellas Europe is focused on four key therapy areas: Transplantation, Urology, Dermatology, and Anti-infectives. These therapy areas are key to Astellas Europe, and the organisation is committed to continuing to explore opportunities and to developing new products that will better serve patients affected by conditions across these areas.
For more information, visit


About euroscript

euroscript International is a leader in providing customers with global solutions in content lifecycle management. The euroscript divisions deliver comprehensive solutions that help customers design, build and run content management operations of all sizes. Thanks to its employees’ expertise in the fields of consulting, system integration, language services as well as content and document management, euroscript is able to help businesses worldwide to manage content more efficiently.

With a market presence in over 14 countries, spanning 4 continents, euroscript serves customers in a variety of business sectors including the public sector, aerospace, defence and transport, manufacturing, financial services and energy and environment.
For more information, visit


Press contacts:

Suzan Ger | Marketing Coordinator
euroscript International S.A. | 55, rue de Luxembourg | L-8077 Bertrange

René Blanken | Managing Director
euroscript Delt Netherlands bv & euroscript Delt Belgium sprl/bvba
T: +31 (0)40 250 79 00

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release euroscript implements Fast-track CMS solution at Astellas Pharma Europe here

News-ID: 111888 • Views: 1221

More Releases from euroscript International S.A.

euroscript setting up in China
Bertrange | 02 May 2012 – euroscript international pursues its worldwide expansion and reinforces its Asian footprint with the opening of a new office in Suzhou, China In line with its international expansion policy triggered during the past decade, euroscript, the world content management solutions provider, has just opened a new office in Suzhou, China, to reinforce its network. China, the powerful nation that has pushed the world economy forward
euroscript becomes ITyX’s new integration partner
Bertrange | 24 January 2012 – euroscript has decided to team up with ITyX to offer its customers truly intelligent software technologies. euroscript, the leading provider in global content lifecycle management solutions, and ITyX have signed an agreement allowing euroscript to offer its customers ITyX innovative solutions. Based on the analysis and utilization of human behavior, ITyX technologies automatically adapt to integrate the usage being made of them, so as to
euroscript signs an exclusive partnership with Basware
Bertrange | 10 January 2012 – euroscript acquires a new technology partner and reinforces its capability to integrate content management technologies that better respond to customers’ content-centric technologies’ issues. euroscript, the leading provider of global content lifecycle management solutions, is proud to announce that it has just concluded an exclusive partnership with Basware, the leading provider of purchase-to-pay solutions. The agreement will enable euroscript to deliver Basware solutions to all
Luxembourg state decides for migration-center
Braunschweig / Bertrange | 25 October 2011 – fme AG and their international business partner euroscript, based in Luxembourg, are proud to announce that they now count a new customer for migration-center. The Centre des Technologies de l'Information de l'Etat (CTIE) as central office for information technology solutions of the state of Luxembourg has decided to use fme’s migration product because of its simple configuration and easy-to-use customization capabilities. CTIE was

All 5 Releases

More Releases for Astellas

Regenerative Medicine market - Thematic Research (Arthrex, Astellas Pharma, Athe …
A new research document is added in HTF MI database of 24 pages, titled as 'Regenerative Medicine - Thematic Research' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Arthrex, Astellas Pharma, Athersys, Bayer, BioCardia, CartiHeal, DiscGenics, Fresenius, Gilead, J&J (DePuy), Medtronic, Novartis, SanBio, Sangamo Therapeutics, Sernova, Smith & Nephew, Stryker, Vericel,
Fidaxomicin Market Research Report - Global Forecast till 2023 | Astellas, Merck …
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Fidaxomicin market. It sheds light on how the global Fidaxomicin Market is expected to grow during the course of the forecast period. With SWOT analysis and Porter’s Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Fidaxomicin market and different players operating therein.
Global Aspergillosis Drugs Market 2017 - Astellas, Merck, GSK, Taj Pharma
Apex Market Reports, recently published a detailed market research study focused on the "Aspergillosis Drugs Market" across the global, regional and country level. The report provides 360° analysis of "Aspergillosis Drugs Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Aspergillosis Drugs industry, and estimates the future trend of Aspergillosis Drugs market
Tacrolimus Market 2017- Astellas, Novartis, Hisun, recently published a detailed market research study focused on the "Tacrolimus Market" across the global, regional and country level. The report provides 360° analysis of "Tacrolimus Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tacrolimus industry, and estimates the future trend of Tacrolimus market on the basis of this
Next Astellas Site will Implement Werum’s PAS-X
Next Astellas Site will Implement Werum’s PAS-X One of the leading Japanese pharma groups chooses Werum again Lueneburg, Germany, 24 April 2012 – Astellas Ireland Co. Ltd. (Kerry Plant) has decided to implement Werum´s PAS-X MES at its production facility in Killorglin, County Kerry, Ireland. The MES will introduce efficient and state-of-the-art paperless Electronic Batch Recording functionality supporting compliant, efficient and lean production processes. The MES will be fully integrated with the
Astellas Pharma and BioFocus sign target discovery agreement
BioFocus announced today that it has signed a collaboration agreement with Astellas Pharma Inc. focused on discovering novel targets in the field of CNS disorders. Under the agreement, BioFocus will utilize its SilenceSelect® target discovery platform to deliver validated targets to enhance the Astellas neurology pipeline and will receive research funding and success payments based on the progress of the collaboration. “We are delighted to support Astellas Pharma